Sign In
Buy TMO
$473.95
-8.13 (-1.69%)
At Close: Jun 03, 2026
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
10:29am, Wednesday, 29'th Oct 2025
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research business amid a strong rebound in demand in
Sethi: Thermo Fisher is a world-class compounder you want in your portfolio
07:31am, Wednesday, 29'th Oct 2025
Sarat Sethi, Managing Partner at DCLA, highlights opportunities in undervalued sectors like healthcare and diagnostics, says trade clarity could boost growth, and calls Thermo Fisher a standout pick.
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion
06:53am, Wednesday, 29'th Oct 2025
Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for $8.88 billion in cash.
Thermo Fisher to buy clinical services provider Clario
06:11am, Wednesday, 29'th Oct 2025
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for about $8.9 billion in cash and future payments, strengthening the life science firm's presence in digital
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading prov
Miles Wu, 14, from New York City, won the $25,000 Thermo Fisher Scientific ASCEND Award, the top award in the Thermo Fisher Junior Innovators Challenge.
Thermo Fisher nears $10 billion takeover of drug trial software maker Clario, FT reports
09:35pm, Tuesday, 28'th Oct 2025
Life sciences group Thermo Fisher is nearing an all-cash takeover of drug trial software maker Clario in a deal that could value the healthcare technology group at approximately $10 billion, the Finan
Thermo Fisher Scientific Enables Semiconductor Manufacturers to See the Unseen with Helios MX1 PFIB-SEM
08:30am, Tuesday, 28'th Oct 2025
WALTHAM, Mass.--(BUSINESS WIRE)--From smartphones to autonomous cars to AI supercomputers, nearly every electronic innovation we use today depends on complicated structures at the atomic scale within
Thermo Fisher's Pullback Is Setting Up Its Next Phase of Growth
12:59pm, Monday, 27'th Oct 2025
Bought 18,686 shares; estimated trade size ~$8.70 million based on quarterly average price for Q3 2025 Transaction represents 0.2% of fund's 13F reportable assets under management Post-trade position:
FRANKFURT, Germany--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceut
Thermo Fisher Scientific: More Upside Likely As Headwinds Continue To Fade And Valuation Still Attractive
04:35am, Saturday, 25'th Oct 2025
Thermo Fisher is well-positioned for continued revenue growth driven by easing pharma uncertainty, reshoring, and recovering clinical research trends. Margins should expand through operating leverage,
Smart Acquisitions And Profit Margin Growth Amid Strategic Repositioning
04:30am, Friday, 24'th Oct 2025
We purchased several new fund holdings across various sectors. Sempra has been shifting its strategic focus from its highly regulated California operations to its growing presence in Texas. Regeneron
Best Medical Stocks To Research – October 22nd
02:50am, Friday, 24'th Oct 2025
Intuitive Surgical, UnitedHealth Group, Eli Lilly and Company, Boston Scientific, Thermo Fisher Scientific, Hims and Hers Health, and Danaher are the seven Medical stocks to watch today, according to
Thermo Fisher Scientific Launches Industry-First Orbitrap Mass Detector for Environmental and Food Safety Testing
08:15am, Thursday, 23'rd Oct 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ Orbitrap Exploris™ EFOX Mass Detector, the industry's first
Thermo Fisher: Recuperation And Macroeconomic Tailwinds Will Unlock Value
08:00am, Thursday, 23'rd Oct 2025
The company successfully concluded its $4,000 million repurchase program, creating value for shareholders. In Q3 2024, Thermo Fisher's revenues increased by 4.94%, a symptom that the company has impro
